Breast Cancer Clinical Trial
— PSYCHONICOfficial title:
Retrospective and Prospective Observational Study on Cardiological and Oncological Psychosomatics
NCT number | NCT03437642 |
Other study ID # | v24-9-2017 |
Secondary ID | |
Status | Recruiting |
Phase | |
First received | |
Last updated | |
Start date | March 27, 2018 |
Est. completion date | December 2022 |
Psychological processes play a complex role in the pathophysiology of many diseases. However,
the body and emotional perception of patients and the relationship between dreams and disease
still need to be investigated.
The investigators planned an observational and controlled research aimed at assessing some
previously unaddressed baseline psychological characteristics and their changes at 1 and 5
years after a short-term psychotherapy in carefully characterised patients with heart or
oncologic diseases .
The patients that will be enrolled are:
- 50 patients ≤ 75 year old with acute myocardial infarction;
- 30 patients ≤ 75 year old with Tako-Tsubo syndrome;
- 50 women ≤ 75 year old, recently operated on breast cancer:
- 90 control subjects of the same age and gender of the enrolled patients, without
relevant pathologies during the last 10 years. Relevant pathologies are defined as those
that required a hospitalisation or a long-lasting medical therapy.
At the enrolment all the subjects will undergo a complete medical evaluation, and the
following psychometric tests: Self-evaluation test, Social Support Questionnaire, Beck
Depression Inventory II (BDI II), MacNew Heart Disease Health-Related Quality of Life
Questionnaire, State-Trait Anxiety Inventory (STAI), State-Trait Anger Expression Inventory
(STAXI 2).
In two distinct following meetings, an open questionnaire exploring the body and emotional
perception, and another exploring past and recent dreams, will be administered.
The same evaluation will be done for the healthy subjects.
After the initial evaluation, all the patients will be given the choice to start a short-term
psychotherapy lasting 6 months on top of medical therapy or to continue classic medical
therapy only. Healthy subjects will be not offered the possibility to follow psychotherapy.
At first year of follow-up, the battery of psychometric test, and the two questionnaires
exploring the body and emotional perception, and changes and characteristics of dreams during
the psychotherapy, will be re-administered.
The following data will be evaluated:
Psychological characteristics at follow-up. Incidence of new relevant medical events Quality
of life Relationship between psychological characteristics and health status, and quality of
life
At 5 year follow-up psychometric tests and the clinical data will be evaluated in all the
groups.
Status | Recruiting |
Enrollment | 220 |
Est. completion date | December 2022 |
Est. primary completion date | December 2022 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 18 Years to 75 Years |
Eligibility |
Inclusion Criteria: - Patients within one week from an Acute myocardial infarction treated with primary or urgent PCI - Patients within one week from the onset of Tako Tsubo cardiomyopathy. - Patients with a diagnosis of breast cancer in the preceding six months - Age and sex matched control subjects without relevant medical pathologies in the preceding 10 years Exclusion Criteria: - Cognitive impairment - Refusing the enrolment |
Country | Name | City | State |
---|---|---|---|
Italy | San Filippo Neri General Hospital | Roma |
Lead Sponsor | Collaborator |
---|---|
San Filippo Neri General Hospital |
Italy,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Cumulative incidence of new relevant medical events | Relevant medical events are defined as any new medical condition significantly impairing normal daily activities or requiring hospitalization or needing specific and permanent drug treatment. | at 1 year | |
Secondary | Cumulative incidence of new relevant medical events | Relevant medical events are defined as any new medical condition significantly impairing normal daily activities or requiring hospitalization or needing specific and permanent drug treatment. | at 5 years | |
Secondary | Changes in body perception and dreams | These changes will be evaluated with dedicated qualitative questionnaires formulated with open questions. | at 1 year | |
Secondary | Incidence of rehospitalisations | Number of rehospitalisations during the first year of follow-up | at 1 year | |
Secondary | Incidence of rehospitalisations | Number of rehospitalisations during 5 years follow-up | at 5 years | |
Secondary | Distress grade | Self-evaluation test (score range 1-10, higher stress for higher values) | at 1 year | |
Secondary | Distress grade | Self-evaluation test (score range 1-10, higher stress for higher values) | at 5 years | |
Secondary | Depression symptoms | Beck depression inventory II (score range 0-63, more severe depression symptoms for higher values) | at 1 year | |
Secondary | Depression symptoms | Beck depression inventory II (score range 0-63, more severe depression symptoms for higher values) | at 5 years | |
Secondary | Social support | Social support questionnaire (score range 12-72, the higher the score the lower the support) | at 1 year | |
Secondary | Social support | Social support questionnaire (score range 12-72, the higher the score the lower the support) | at 5 year | |
Secondary | Quality of life | Mac New Health-related quality of life questionnaire (score range 1-7, the higher the score the higher the quality of life, 4 subscales not merged) | at 1 year | |
Secondary | Quality of life | Mac New Health-related quality of life questionnaire (score range 1-7, the higher the score the higher the quality of life, 4 subscales not merged) | at 5 years | |
Secondary | Anxiety grade | State-Trait Anxiety inventory (score range 20-80, the higher the score the more anxiety the patients has, 2 subscales) | At 1 year | |
Secondary | Anxiety grade | State-Trait Anxiety inventory (score range 20-80, the higher the score the more anxiety the patients has, 2 subscales) | At 5 years | |
Secondary | Anger level | State-Trait Anger Expression inventory (score range 0%-100%, the higher the score the higher the anger, two subscales) | at 1 year | |
Secondary | Anger level | State-Trait Anger Expression inventory (score range 0%-100%, the higher the score the higher the anger, two subscales) | at 5 years |
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT04681911 -
Inetetamab Combined With Pyrotinib and Chemotherapy in the Treatment of HER2 Positive Metastatic Breast Cancer
|
Phase 2 | |
Completed |
NCT04890327 -
Web-based Family History Tool
|
N/A | |
Terminated |
NCT04066790 -
Pyrotinib or Trastuzumab Plus Nab-paclitaxel as Neoadjuvant Therapy in HER2-positive Breast Cancer
|
Phase 2 | |
Completed |
NCT03591848 -
Pilot Study of a Web-based Decision Aid for Young Women With Breast Cancer, During the Proposal for Preservation of Fertility
|
N/A | |
Recruiting |
NCT03954197 -
Evaluation of Priming Before in Vitro Maturation for Fertility Preservation in Breast Cancer Patients
|
N/A | |
Terminated |
NCT02202746 -
A Study to Assess the Safety and Efficacy of the VEGFR-FGFR-PDGFR Inhibitor, Lucitanib, Given to Patients With Metastatic Breast Cancer
|
Phase 2 | |
Active, not recruiting |
NCT01472094 -
The Hurria Older PatiEnts (HOPE) With Breast Cancer Study
|
||
Withdrawn |
NCT06057636 -
Hypnosis for Pain in Black Women With Advanced Breast Cancer: A Feasibility Study
|
N/A | |
Completed |
NCT06049446 -
Combining CEM and Magnetic Seed Localization of Non-Palpable Breast Tumors
|
||
Recruiting |
NCT05560334 -
A Single-Arm, Open, Exploratory Clinical Study of Pemigatinib in the Treatment of HER2-negative Advanced Breast Cancer Patients With FGFR Alterations
|
Phase 2 | |
Active, not recruiting |
NCT05501769 -
ARV-471 in Combination With Everolimus for the Treatment of Advanced or Metastatic ER+, HER2- Breast Cancer
|
Phase 1 | |
Recruiting |
NCT04631835 -
Phase I Study of the HS-10352 in Patients With Advanced Breast Cancer
|
Phase 1 | |
Completed |
NCT04307407 -
Exercise in Breast Cancer Survivors
|
N/A | |
Recruiting |
NCT03544762 -
Correlation of 16α-[18F]Fluoro-17β-estradiol PET Imaging With ESR1 Mutation
|
Phase 3 | |
Terminated |
NCT02482389 -
Study of Preoperative Boost Radiotherapy
|
N/A | |
Enrolling by invitation |
NCT00068003 -
Harvesting Cells for Experimental Cancer Treatments
|
||
Completed |
NCT00226967 -
Stress, Diurnal Cortisol, and Breast Cancer Survival
|
||
Recruiting |
NCT06037954 -
A Study of Mental Health Care in People With Cancer
|
N/A | |
Recruiting |
NCT06019325 -
Rhomboid Intercostal Plane Block on Chronic Pain Incidence and Acute Pain Scores After Mastectomy
|
N/A | |
Recruiting |
NCT06006390 -
CEA Targeting Chimeric Antigen Receptor T Lymphocytes (CAR-T) in the Treatment of CEA Positive Advanced Solid Tumors
|
Phase 1/Phase 2 |